Z17.421 Billable / specific Hormone receptor negative with human epidermal growth factor receptor 2 negative status

ICD-10-CM Z17.421 identifies “Hormone receptor negative with human epidermal growth factor receptor 2 negative status” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.

Chapter 21: Factors influencing health status and contact with health services

Exempt from present-on-admission reporting

Code-level instructions

Inclusion terms3
  • HR- with HER2-
  • TNBC
  • Triple negative breast cancer

Inherited instructions

Z17 · Estrogen, and other hormones and factors receptor status

Code first3
  • malignant neoplasm, such as:
  • malignant neoplasm of breast (C50.-)
  • malignant neoplasm of ovary (C56.-)
Note1

Use one code, as available, for each receptor: Z17.0, Z17.1, Z17.2-, Z17.3-

Chapters 21 · Factors influencing health status and contact with health services (Z00-Z99)

Note3
  • Z codes represent reasons for encounters. A corresponding procedure code must accompany a Z code if a procedure is performed. Categories Z00-Z99 are provided for occasions when circumstances other than a disease, injury or external cause classifiable to categories A00-Y89 are recorded as 'diagnoses' or 'problems'. This can arise in two main ways:
  • (a) When a person who may or may not be sick encounters the health services for some specific purpose, such as to receive limited care or service for a current condition, to donate an organ or tissue, to receive prophylactic vaccination (immunization), or to discuss a problem which is in itself not a disease or injury.
  • (b) When some circumstance or problem is present which influences the person's health status but is not in itself a current illness or injury.

Z17.4 · Combined receptor status

Note1

Assign a code from subcategory Z17.4- when only a combined receptor status is documented

Z17.42 · Hormone receptor negative

Inclusion terms1

HR-

Official index references

Official index references (2)

Status(post) (1)
Triple (1)

Official conversion history

Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.

Release dates 2024-10-01

Previous assignment: None

History

Code history

Latest recorded change · FY2025

ChangedUnchanged
FY2025

Effective from

  • Added

Hormone receptor negative with human epidermal growth factor receptor 2 negative status

Billable diagnosis code

CDC/NCHS · FY2025

All editions (5)

All editionsEffective fromCode history
FY20252024-10-01Added
FY2025 · 04-012025-04-01No tabular change
FY20262025-10-01No tabular change
FY2026 · April2026-04-01No tabular change
FY20272026-10-01No tabular change

This entry is a complete code in the selected edition. Reference checks do not establish clinical appropriateness or guarantee reimbursement.